📖
Early dynamics of eosinophils and the neutrophil-to-lymphocyte ratio are associated with severe immune-related adverse events during nivolumab therapy for metastatic renal cell carcinoma.
Fiala O, Králíček J, Kopecký J, Vočka M, Buchler T, Študentová H, Obertová J, Rondzíková B, Matějů M, Šafčák D, Hrnčár M, Priester P, Spisarová M, Zemánková A, Lohynská R, Tkadlecová M, Grmelová L, Stránský P Jr, Melichar B, Palacka P, Poprach A

Early dynamics of eosinophils and the neutrophil-to-lymphocyte ratio are associated with severe immune-related adverse events during nivolumab therapy for metastatic renal cell carcinoma.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Front Immunol.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Early dynamics of eosinophils and the neutrophil-to-lymphocyte ratio are associated with severe immune-related adverse events during nivolumab therapy for metastatic renal cell carcinoma.
Author / Organization Fiala O, Králíček J, Kopecký J, Vočka M, Buchler T, Študentová H, Obertová J, Rondzíková B, Matějů M, Šafčák D, Hrnčár M, Priester P, Spisarová M, Zemánková A, Lohynská R, Tkadlecová M, Grmelová L, Stránský P Jr, Melichar B, Palacka P, Poprach A
Subject & Discipline Front Immunol
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-120649
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »